About Disto Pharmaceuticals Private Limited
Data last updated: 18 December 2025
Disto Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 09 May 2002, the company has been in operation for over 24 years.
Registered with ROC Hyderabad under CIN U24239AP2002PTC038926.
Capital: an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.56 Cr. It is led by directors including Asith Kumar Mukherjee and Harish Chandra Pandey.
Last AGM: 30 September 2024. Financial statements filed for year ended 31 March 2024. Office: Plot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051.
As per the financials filed for FY 2024, the company reported a revenue of ₹22.63 Cr, a decline of 5% compared to the previous year.
The company has a workforce of approximately 75 employees as per the latest available data.
The company is associated with 1 brand - Disto Pharmaceuticals. As per MCA filings, the company has open charges of ₹18.87 Cr and satisfied charges of ₹1.95 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website distopharma.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressPlot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Disto Pharmaceuticals Private Limited
Disto Pharmaceuticals Private Limited has one previous CIN (Corporate Identification Number): U24239AP2002PTC038926. The current CIN is U24239TG2002PTC038926, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2002PTC038926 | Current |
| U24239AP2002PTC038926 | Previous |
Associated Brands with Disto Pharmaceuticals Private Limited
Disto Pharmaceuticals Private Limited operates one associated brand: Disto Pharmaceuticals. These brands represent Disto Pharmaceuticals Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures pharmaceutical pellets, granules, tablets, and capsules. | distopharma.com |
Competitors & Alternatives of Disto Pharmaceuticals Private Limited
Brands and companies operating in the same space as Disto Pharmaceuticals Private Limited include Encube Ethicals, Famar, Crown Laboratories and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Encube Ethicals
|
Contract development and manufacturing for topical semisolid formulations are provided. | Mumbai, India, India | 1998 |
Famar
|
Contract manufacturing and development services provider | Athens, Greece, Greece | 1949 |
Crown Laboratories
|
OTC, prescription, skin care, and oral care products are manufactured. | Johnson City, United States, United States | 2000 |
Formulated Solutions
|
Company offering CDMO services for the pharma (Rx and OTC), medical device, personal care and veterinary medicine sectors | Largo, United States, United States | 1999 |
Curida
|
Liquid pharmaceuticals are developed via blow fill seal technology. | Elverum, Norway, Norway | 2015 |
Chemineau Labs
|
CDMO specializing in ENT and topical dosage forms | Vouvray, France, France | 1947 |
Contract Pharmaceuticals
|
CDMO focused on manufacturing of semi-solid pharmaceutical drugs | Mississauga, Canada, Canada | 1991 |
Pharmasol
|
Pharmasol is recognized as a Contract Development and Manufacturing Organization. | Easton, United States, United States | 1996 |
Business Activity of Disto Pharmaceuticals Private Limited
Disto Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Disto Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Disto Pharmaceuticals Private Limited
Disto Pharmaceuticals Private Limited is currently managed by 4 directors, with 6 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Asith Kumar Mukherjee
Also directs:
Vive Medsolutions Private Limited
|
Managing Director | 15 Sep 2009 | 16 Years 11 Months | Current |
|
Harish Chandra Pandey
Also directs:
Vive Medsolutions Private Limited
|
Director | 15 Sep 2009 | 16 Years 11 Months | Current |
| Bidesh Mukherjee | Whole-Time Director | 15 Oct 2022 | 3 Years 10 Months | Current |
| Krishna Raj Pandey | Whole-Time Director | 15 Oct 2022 | 3 Years 10 Months | Current |
Financials of Disto Pharmaceuticals Private Limited FY 2024 filings available
Disto Pharmaceuticals Private Limited reported revenue of ₹22.63 Cr (down 5.00% YoY) for FY 2024.
Ten-year financial statements for Disto Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of Disto Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Oct 2025 | Uco Bank | ₹9.61 Cr | Open |
| 03 Dec 2024 | Uco Bank | ₹84 Lakh | Open |
| 18 Sep 2024 | Uco Bank | ₹11.8 Lakh | Open |
| 05 Jul 2024 | Hdfc Bank Limited | ₹17.5 Lakh | Open |
| 28 May 2024 | Hdfc Bank Limited | ₹22.05 Lakh | Open |
Total charge records: 11 View all charges
Employees and EPFO Compliance at Disto Pharmaceuticals Private Limited
View historical data on people associated with Disto Pharmaceuticals Private Limited, including employment history and EPFO contributions.
Employee and EPFO history for Disto Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Disto Pharmaceuticals Private Limited
GST registrations and filing compliance for Disto Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Disto Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Disto Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Disto Pharmaceuticals Private Limited
MSME payment history for Disto Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Disto Pharmaceuticals Private Limited
Corporate group structure for Disto Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Disto Pharmaceuticals Private Limited
MCA filings and documents for Disto Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Disto Pharmaceuticals Private Limited
Frequently Asked Questions about Disto Pharmaceuticals Private Limited
Disto Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Hyderabad, Telangana, India. It was incorporated on 09 May 2002 (24+ years old) and is registered under CIN U24239TG2002PTC038926. The company has 75 employees.
Disto Pharmaceuticals Private Limited reported revenue of ₹22.63 Cr for FY 2024 (down 5.00% YoY).
The current directors of Disto Pharmaceuticals Private Limited are:
- Asith Kumar Mukherjee - Managing Director
- Harish Chandra Pandey - Director
- Bidesh Mukherjee - Whole-Time Director
- Krishna Raj Pandey - Whole-Time Director
The primary industry of Disto Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Disto Pharmaceuticals Private Limited can be reached at the registered office: Plot No – 22 Phase – I Cherlapally Industrial Area, Hyderabad, Telangana, India – 500051, or through the website distopharma.com.
The authorised capital is ₹5 Cr, and the paid-up capital is ₹4.56 Cr.